Message below is a paid advertisement. Content is provided by the sponsor.
 
A SPECIAL
ANNOUNCEMENT FROM:
  LCGC Logo  

 
Gene to Antibody
 
GenScript™ serves as a partner for researchers in basic life sciences, translational and biomedical fields as well as early-stage drug development. We offer the best-in-class capacity and capability in both technology and expertise to support your antibody drug discovery process. In need of recombinant antibodies for epitope binning, affinity measurements, drug screening, biophysical characterization, or other screening applications? Try GenScript’s upgraded, high throughput gene to antibody service and get up to 1mg of purified recombinant antibody in just 4 weeks!

Fatest turnaround time
High capacity
Competitive Pricing
Fastest Turnaround
Time in the Industry
High Capacity to Handle Any
Recombinant Antibody Project
Cost Effective Option
for your Investment
Express delivery of your antibodies in just 18 days! GenScript has successfully delivered more than 3,000 recombinant antibody projects. One-stop solution: From gene synthesis to purified recombinant antibody.


Service Features:

Starting material Expression Amount Timeline List price Deliverable
Antibody sequence (minimum 8 antibodies) Mammalian 50µg 4 weeks $499/Ab  • 1-step affinity purified antibody as specified
 • QC data
1mg $799/Ab

HTP Gene to Antibody Production Workflow
HTP Gene to Antibody Production Workflow

button

Would you like to learn how GenScript recombinant protein, antibody and cell line services can help accelerate your research? Click below to indicate your preference for a no-obligation follow up from our team member.

TECHNICAL NOTES:
Antibody Drug Discovery is a complex subject. How much do you know? Review basics.
Antibody reference dates back to 1890. Learn more about the history of these molecules.
How much do you know about the ubiquitous IgG molecule? Test your knowledge.
Bispecific Antibodies are playing an important role in cancer immunotherapy. Learn how.
Webinar
Webinars:
Recombinant antibody production in therapeutic antibody projects
Development of a Potential Recombinant Protein Vaccine in E.coli
Optimizing Soluble Protein Expression
Chaperone Co-expression Strategies for Protein Expression
 
You received this email because you are a customer of BioPharm International, a UBM publication. You are on the mailing list as %%emailaddress%%.